| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
134,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,528,949 |
Avg
Vol: |
709,262 |
| 52
Week Range: |
$24.45 - $24.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Standring David |
EVP, Biology |
• – – |
2009-11-11 |
4 |
OE |
$1.00 |
$15,000 |
D/D |
15,000 |
67,375 |
|
- |
|
| Novartis Pharma Ag |
10% OWNER |
– – • |
2009-08-21 |
4/A |
B |
$2.41 |
$8,606 |
I/I |
3,571 |
31,320,964 |
1.5 |
- |
|
| Novartis Pharma Ag |
10% OWNER |
– – • |
2009-05-29 |
4 |
B |
$2.62 |
$6,422 |
I/I |
2,451 |
31,317,393 |
1.5 |
- |
|
| Novartis Pharma Ag |
10% owner |
– – • |
2009-02-23 |
4 |
B |
$2.41 |
$13,120 |
I/I |
5,444 |
31,314,942 |
1.5 |
- |
|
| Novartis Pharma Ag |
10% OWNER |
– – • |
2008-11-19 |
4 |
B |
$4.05 |
$19,225 |
I/I |
4,747 |
31,309,498 |
1.5 |
- |
|
| Sommadossi Jean-Pierre |
President, CEO, Chairman |
• • – |
2008-09-16 |
4 |
D |
$8.00 |
$880,000 |
D/D |
(110,000) |
2,058,569 |
|
- |
|
| Novartis Pharma Ag |
10% Owner |
– – • |
2008-09-02 |
4 |
B |
$2.93 |
$13,636 |
I/I |
4,654 |
31,304,751 |
1.5 |
- |
|
| Novartis Pharma Ag |
10% Owner |
– – • |
2008-05-29 |
4 |
B |
$2.41 |
$2,227 |
I/I |
924 |
31,300,097 |
1.42 |
- |
|
| Weidenbruch John |
Ex. VP, Gen. Counsel and Secr. |
• – – |
2008-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
2.66 |
- |
|
| Mayers Douglas L |
EVP and Chief Medical Officer |
• – – |
2008-03-11 |
4 |
B |
$4.45 |
$133,500 |
I/I |
30,000 |
30,000 |
1.99 |
- |
|
| Renaud Ronald C Jr |
Chief Financial Officer |
• – – |
2008-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
2.66 |
- |
|
| Standring David |
EVP, BiologyOfficer |
• – – |
2008-02-22 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
52,375 |
|
- |
|
| Standring David |
EVP, BiologyOfficer |
• – – |
2008-02-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
200 |
|
- |
|
| Standring David |
EVP, BiologyOfficer |
• – – |
2008-02-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,000 |
|
- |
|
| Fanning Paul |
SVP, Human ResourcesOfficer |
• – – |
2008-02-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,333 |
|
- |
|
| Koppy Susan |
Sr. VP, Business and Corp Dev. |
• – – |
2007-07-13 |
4 |
B |
$3.84 |
$1,536 |
D/D |
400 |
650 |
2.66 |
- |
|
| Novartis Pharma Ag |
10% Owner |
– – • |
2006-06-06 |
4 |
B |
$20.48 |
$7,475 |
I/I |
365 |
31,299,173 |
1.5 |
- |
|
| Sommadossi Jean-Pierre |
President, CEO, Chairman |
• • – |
2006-05-09 |
4 |
B |
$9.13 |
$91,300 |
D/D |
10,000 |
2,058,269 |
2.81 |
- |
|
| Koppy Susan |
Sr. VP, Business and Corp Dev. |
• – – |
2006-05-08 |
4 |
B |
$9.26 |
$1,852 |
D/D |
200 |
250 |
2.66 |
- |
|
| Novartis Pharma Ag |
10% Owner |
– – • |
2006-04-04 |
4 |
B |
$16.23 |
$47,684 |
I/I |
2,938 |
31,298,808 |
1.5 |
- |
|
| Koppy Susan |
Sr. VP, Business and Corp Dev. |
• – – |
2006-01-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
50 |
|
- |
|
| Pollard-Knight Denise |
Director |
– • – |
2005-11-14 |
4 |
S |
$20.61 |
$12,973,954 |
I/I |
(629,498) |
301,476 |
|
- |
|
| Novartis Pharma Ag |
10% Owner |
– – • |
2005-10-31 |
4 |
B |
$20.61 |
$81,185,490 |
I/I |
3,939,131 |
31,295,870 |
1.5 |
- |
|
| Novartis Pharma Ag |
10% Owner |
– – • |
2005-09-02 |
4 |
A |
$20.18 |
$23,955,537 |
I/I |
1,187,093 |
27,356,739 |
|
- |
|
| Sommadossi Jean-Pierre |
President, CEO, Chairman |
• • – |
2005-04-06 |
5 |
GD |
$0.00 |
$0 |
I/I |
159,345 |
0 |
|
- |
|
77 Records found
|
|
Page 2 of 4 |
|
|
